Telehealth Ketamine in New York: Access, Laws, and What to Know

Quick Answer for New York

As of 2026, New York is broadly aligned with the federal Ryan Haight Act floor and standard state medical board telehealth rules. Telehealth ketamine care for New York residents is governed by the New York State Board for Medicine together with federal DEA rules under the Ryan Haight Online Pharmacy Consumer Protection Act. Patients should verify current requirements with the New York State Board for Medicine before starting care, as state telehealth and controlled substance rules continue to evolve.

Is ketamine telehealth legal in New York?

Telehealth ketamine is legal in New York when prescribed under the federal Ryan Haight Act standard and the state medical board's telehealth rules. Ketamine is a Schedule III controlled substance, so prescribers must establish a valid provider-patient relationship — typically through a real-time audio-visual evaluation — and follow New York State Board for Medicine documentation and standard-of-care expectations. Because telehealth controlled substance rules continue to change at both the federal and state level, verify the most current requirements with the New York State Board for Medicine before scheduling care.

Does New York Medicaid cover Spravato or telehealth ketamine?

Insurance coverage varies in New York. New York Medicaid is among the more accommodating state Medicaid programs for Spravato, with coverage available under prior authorization; off-label ketamine is patient-pay. Commercial insurance coverage for Spravato is more common when criteria for treatment-resistant depression are met, while compounded oral, sublingual, and IM ketamine for off-label uses is typically self-pay. Patients should contact their plan directly and ask about prior authorization requirements.

Can a nurse practitioner prescribe ketamine via telehealth in New York?

New York nurse practitioners with more than 3,600 hours of qualifying experience may practice and prescribe Schedule III controlled substances independently. This means the prescriber on a telehealth ketamine visit may be a physician, a nurse practitioner, or — depending on state scope-of-practice rules — a physician assistant. Patients can confirm a prescriber's license and scope of practice through the New York State Board for Medicine or the appropriate New York nursing board.

Do I need an in-person visit before telehealth ketamine in New York?

As of 2026, federal DEA flexibilities extended during and after the COVID-19 public health emergency continue to allow many telehealth ketamine evaluations without a prior in-person visit, but this is subject to ongoing federal rulemaking. New York generally does not require an additional state-specific in-person visit beyond federal expectations. Always verify current rules with the New York State Board for Medicine before assuming a fully remote pathway is available.

Overview

Telehealth ketamine therapy is widely available in New York, one of the largest healthcare markets in the United States. The state has a well-developed telehealth regulatory framework, a large provider network, and strong patient protections. New York residents—from Manhattan to the rural Adirondacks—can access telehealth ketamine treatment for conditions including treatment-resistant depression, anxiety disorders, and PTSD.

Regulatory Environment

New York has comprehensive telehealth legislation, primarily codified in Public Health Law Article 29-G and Education Law provisions governing telemedicine practice. The state permits licensed providers to deliver healthcare via telehealth, establish provider-patient relationships remotely, and prescribe medications including controlled substances when clinically appropriate.

The New York State Department of Health and the New York State Education Department (which oversees professional licensing through the Office of the Professions) regulate medical practice in the state. The New York State Board of Pharmacy governs pharmaceutical practice and compounding.

Ketamine is a Schedule III controlled substance under New York law. The state's Bureau of Narcotic Enforcement within the Department of Health monitors controlled substance prescribing through the Internet System for Tracking Over-Prescribing (I-STOP) program and the Prescription Monitoring Program (PMP). Providers prescribing ketamine must check the PMP registry before issuing prescriptions.

New York does not participate in the Interstate Medical Licensure Compact, which means out-of-state providers must obtain full New York licensure to treat patients in the state. This can somewhat limit the pool of available telehealth providers compared to compact member states, though New York's large market still attracts significant provider participation.

Provider Availability

Provider availability in New York is high. The state's massive population and concentrated healthcare industry mean numerous telehealth platforms and individual providers serve New York patients. The competitive market provides patients with substantial choice in terms of provider qualifications, treatment approaches, pricing, and availability.

Patients in New York City and its suburbs have particularly abundant options, but telehealth ensures that residents of upstate New York, the Hudson Valley, and western New York also have access to ketamine-specialized providers.

Compounding Pharmacy Access

New York has a large and well-regulated compounding pharmacy sector. The New York State Board of Pharmacy oversees compounding activities and enforces compliance with USP standards. Numerous in-state compounding pharmacies prepare ketamine formulations, and out-of-state pharmacies properly licensed to ship into New York also serve state residents.

Patients in New York can access the full range of compounded ketamine products, including sublingual troches, rapid-dissolve tablets, nasal sprays, and topical formulations. Urban patients may have the option of in-person pharmacy pickup, while patients statewide can receive medications via mail order.

Insurance and Cost Considerations

New York has some of the strongest healthcare consumer protection laws in the nation, including robust mental health parity requirements. Despite this, most private insurers in New York do not specifically cover off-label ketamine for psychiatric conditions (see our insurance coverage guide for details). However, New York's parity laws may support coverage for the psychiatric evaluation and management components of ketamine treatment.

New York Medicaid does not typically cover ketamine for psychiatric off-label use. The state's Medicaid program is administered by the New York State Department of Health, and patients should check current formulary policies for any updates.

The cost of telehealth ketamine treatment in New York tends to be at the higher end of national ranges, reflecting the state's overall higher healthcare costs. Initial evaluations may range from $250 to $600, with monthly treatment costs of $150 to $350. New York City-based providers may charge premium rates. Patients should shop around, as pricing varies significantly between providers.

Key Considerations for New York Patients

Regulatory complexity. New York has one of the more complex healthcare regulatory environments in the country. Patients should verify that their telehealth ketamine provider is fully licensed in New York and compliant with state-specific requirements. Use our provider verification guide for a step-by-step approach.

I-STOP compliance. New York's I-STOP program requires prescribers to consult the Prescription Monitoring Program before issuing controlled substance prescriptions. This is a patient safety measure, and patients should not be concerned about routine PMP checks during the prescribing process.

Urban vs. rural access. While telehealth equalizes access to some degree, patients in rural New York should ensure reliable internet connectivity for video consultations. Many providers also offer phone-based follow-ups for established patients.

Comprehensive care. New York has an extensive network of mental health providers, and patients pursuing ketamine therapy should take advantage of available psychotherapy resources to complement their treatment. Integration of ketamine with psychotherapy has shown promising results in clinical practice.

Cost management. Given New York's higher costs, patients should compare multiple providers, ask about package pricing, and determine whether any portion of treatment can be submitted to insurance for reimbursement.

References

• New York State Education Department — Office of the Professions — Professional licensing for physicians and pharmacists in New York.
• New York State Board of Pharmacy — Regulatory oversight of pharmacy practice and compounding.
• New York State Department of Health — Telehealth — Information on telehealth policy and regulations in New York.